Ability of the UCLA SCTC GITI to differentiate between degrees of severity of self-rated GI tract involvement.
Severity of GI Involvement According to Categorization of GI-S-HAQ Results | p Values for Pairwise Differences Using Tukey’s Honestly Significant Differences Test | |||||||
---|---|---|---|---|---|---|---|---|
Scale | Normal, n = 62 | Mild-moderate, n = 34 | Severe, n = 17 | F Test | p | Mild-moderate vs Normal | Severe vs Normal | Severe vs Mild-moderate |
Reflux | 0.26 | 0.62 | 0.66 | 8.12 | 0.001 | 0.003 | 0.010 | 0.951 |
Distension/bloating | 0.60 | 1.13 | 1.29 | 8.33 | 0.000 | 0.005 | 0.004 | 0.754 |
Diarrhea | 0.18 | 0.41 | 0.74 | 7.83 | 0.001 | 0.104 | 0.001 | 0.107 |
Fecal soilage | 0.16 | 0.62 | 0.53 | 6.12 | 0.003 | 0.004 | 0.102 | 0.892 |
Constipation | 0.32 | 0.71 | 0.56 | 5.04 | 0.008 | 0.007 | 0.299 | 0.669 |
Social functioning | 0.15 | 0.48 | 0.62 | 13.51 | 0.000 | 0.000 | 0.000 | 0.449 |
Emotional well-being | 0.14 | 0.56 | 0.95 | 24.67 | 0.000 | 0.000 | 0.000 | 0.013 |
Total UCLA SCTC GITI score | 0.25 | 0.64 | 0.80 | 20.64 | 0.000 | 0.000 | 0.000 | 0.312 |
UCLA SCTC GITI: University of California at Los Angeles Scleroderma Clinical Trial Consortium GI Tract Instrument; GI: gastrointestinal; GI-S-HAQ: GI scale of the Health Assessment Questionnaire for the Spondyloarthropathies.